MLKL and Alzheimer disease: Experimental evidence shows that in the hippocampus of AD model rats, RIPK1 expression increased 1.79-fold, MLKL increased 2.19-fold, and TNFR1 increased 2.81-fold, leading to activation of the RIPK1-RIPK3-MLKL pathway.